The author studied male Medicare beneficiaries who were potential candidates for prostate biopsies. Urologists who used the “in-office ancillary services” exception to refer patients to a facility in which the physicians have a financial interest billed Medicare for nearly 72 percent more specimens per prostate biopsy than physicians who did not self-refer. In addition, the cancer detection rate of self-referring urologists was 12 percentage points lower than non-self-referring urologists.
The author said the results suggest that self-referring urologists employing the “in-office” exception perform more prostate biopsies on men who are unlikely to have prostate cancer.
More Articles on Physician Self-Referrals:
Maryland Enforces Imaging Self-Referral Law After 5-Year Legal Battle
Study: Imaging Self-Referrals Associated With More Unnecessary Scans
Arkansas’ Baxter Regional Charges Management Firm With Self-Referral Violations
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
